Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing NaN - NaN of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Placebo)

Completed
  • Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +185 more
Jan 30, 2023

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • La Jolla, California
  • +159 more
Jan 23, 2023

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Renal Cell Carcinoma Trial in United States (Nivolumab, Ipilimumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • Muscle Shoals, Alabama
  • +60 more
Oct 6, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Study of Kidney Tumors in Younger Patients

Recruiting
  • Adult Cystic Nephroma
  • +24 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +247 more
Sep 2, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)

Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +2 more
  • Tucson, Arizona
  • +153 more
Jan 13, 2022

Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

Recruiting
  • Melanoma (Excluding Uveal Melanoma)
  • +15 more
  • XmAb®23104
  • Yervoy® (ipilimumab)
  • San Diego, California
  • +15 more
Sep 20, 2021

NSCLC, Renal Cell Carcinoma Trial in Atlanta (Preoperative Ketorolac)

Recruiting
  • Non-small Cell Lung Cancer
  • Renal Cell Carcinoma
  • Preoperative Ketorolac
  • Atlanta, Georgia
  • +3 more
Sep 16, 2021

Ewing's Sarcoma, Osteosarcoma, Astrocytoma Trial in Atlanta (sirolimus)

Completed
  • Ewing's Sarcoma
  • +15 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
May 27, 2020

Renal Cell Carcinoma, Melanoma, Lung Cancer Trial in United States (Infliximab + Prednisone, Methylprednisolone + Prednisone)

Withdrawn
  • Renal Cell Carcinoma
  • +2 more
  • Infliximab + Prednisone
  • Methylprednisolone + Prednisone
  • Los Angeles, California
  • +9 more
Oct 5, 2018

Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

Terminated
  • Advanced Renal Cell Carcinoma
  • +2 more
  • Standard Treatment
  • AGS-003
  • Scottsdale, Arizona
  • +124 more
Jun 13, 2018

Renal Cell Carcinoma Trial in United States (Sorafenib Escalated Dose, Sorafenib Standard Dose)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Sorafenib Escalated Dose
  • Sorafenib Standard Dose
  • Jonesboro, Arkansas
  • +12 more
Jul 17, 2013

Renal Cell Carcinoma Trial in Canada, United States (AGS-003, Sunitinib)

Completed
  • Renal Cell Carcinoma
  • Duarte, California
  • +13 more
Jul 11, 2013